Oncotype DX Breast Cancer Test Less Accurate for Blacks - Cancer Currents Blog

Having trouble viewing this email? View it as a Web page.

You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below.     Oncotype DX Breast Cancer Test May Be Less Accurate for Black Patients 02/26/2021 The test, which helps guide treatment decisions, was not as good at predicting the risk of death from breast cancer for Blacks as for Whites, a new study has found. The findings highlight the need for greater racial diversity in research studies.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892